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Abstract. Using surface immunoprecipitation at 37°C
to "catch" the transient apical or basolateral appearance
of an endogenous MDCK lysosomal membrane glyco-
protein, the AC17 antigen, we demonstrate that the
bulk of newly synthesized AC17 antigen is polarly tar-
geted from the Golgi apparatus to the basolateral plasma
membrane or early endosomes and is then transported
to lysosomes via the endocytic pathway. The AC17 an-
tigen exhibits very similar properties to members of
the family of lysosomal-associated membrane glycopro-
teins (LAMPS). Parallel studies of an avian LAMP,
P
OLARIZED epithelial cells form a cohesive monolayer
in which the apical membrane, facing the lumen, has
a protein and lipidcomposition distinct from the baso-
lateral membrane which faces the internal medium. These
differences are crucial to the role of epithelia in regulating
the flow of water, ions, and other solutes between biological
compartments ofdifferent composition. The two distinct sur-
face domains are separated by the zonula occludens, or tight
junction, which constitutes the main permeability barrier of
the epithelial monolayer (53). Recent work has identifiedtwo
sites where apical and basolateral proteins are sorted during
biogenesis: the trans-Golgi network (TGN)' and the baso-
lateral surface. Viral, endogenous, and transfected proteins
are delivered directly from the TGN, via carrier vesicles, to
the apical and basolateral surfaces of MDCK cells (33, 42,
45, 49, 51, 54, 64). In the hepatocyte, the only route demon-
strated for apical protein delivery is indirect, via the basolat-
eral surface (1, 25). An intermediate phenotype with both
direct and indirect delivery of apical proteins was found in
intestinal cells (34, 43) . An indirect pathway can also exist
in MDCK cells, since the polymeric Ig receptor, which
transports IgA or IgM produced in the lamina propria, fol-
lows a transcytotic (indirect) pathway in all epithelial cells
studied to date (46). No indirect pathway has yet been de-
scribed for basolateral proteins.
1. Abbreviations used in this paper: endo F and H, endoglycosidase F and
H, respectively; LAMP, lysosomal associated membrane glycoproteins;
LAP, lysosomal acid phosphatase; M6P, mannose-6-phosphate; TGN,
trans-Golgi network.
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LEP100, transfected into MDCK cells revealed colo-
calization of the two proteins to lysosomes, identical
biosynthetic and degradation rates, and similar low
levels of steady-state expression on both the apical
(0.8 %) and basolateral (2.1%) membranes. After treat-
ment of the cells with chloroquine, newly synthesized
AC17 antigen, while still initially targeted basolaterally,
appears stably in both the apical and basolateral do-
mains, consistent with the depletion of the AC17 anti-
gen from lysosomes and its recycling in a nonpolar
fashion to the cell surface.
The signals that direct proteins along these pathways are
currently the object of intense study (53, 58). Apical target-
ing information may be present in the ectodomain of viral
glycoproteins (11, 44, 55) and in the glycolipid anchor of
proteins attached to the membrane via a glycosyl phos-
phatidyl inositol linkage (6, 38, 40, 66) . Many rapidly en-
docytosed proteins are basolaterally distributed (16-18, 50),
and recent work has suggested a correlation between the
presence of signals for coated pit internalization in the cyto-
plasmic domain and basolateral targeting in MDCK cells.
An F. receptor isoform containing an internalization signal
is targeted basolaterally, while another isoform differing
solely in the cytoplasmic domain and lacking an internaliza-
tion signal is targeted apically in MDCK cells (26). A cyto-
plasmic deletion that confers endocytic properties to the
nervegrowth factor receptor reverses its polarity from apical
to basolateral in transfected MDCK cells (35). Insertion of
a tyrosine in the cytoplasmic domain of apical influenza
hemagglutinin (HA), normally excluded from coated pits
and poorly endocytosed, results in both coated pit internali-
zation and basolateral targeting (5, 30) . However, the baso-
lateral targeting signal appears to be distinct from the endo-
cytic signal for the polymeric Ig receptor (7).
In addition to sorting apical and basolateral proteins in
epithelia, the TGN also segregates soluble lysosomal en-
zymes from the secretory pathway. Mannose-6-phosphate
(M6P) containing lysosomal enzymes interacts with M6P
receptors in the TUN and are then transported within
clathrin-coated vesicles to an acidic prelysosomal compart-
ment; here the enzyme dissociates from the receptor and is
1573then transported to lysosomes, whereas the free M6P recep-
tors are recycled back to the TGN (13, 62). The M6P recep-
tor-rich compartment is referred to as both the prelysosome
and the late endosome and the two terms will be used inter-
changeably throughoutthe text. At steady state, M6P recep-
tors are predominantly localized to prelysosomes but are
also found in the TGN, peripheral endosomes, and the
plasma membrane (22) .
Integral membrane lysosomal glycoproteins lack the M6P
signal and are still targeted to lysosomes (28). Lysosomal
acid phosphatase (LAP), a transmembrane glycoprotein
lacking an M6P signal, is transported via the cell surface to
the lysosome, where it is proteolytically cleaved to release
soluble enzyme (4, 48, 63). A family oflysosomal associated
membrane glycoproteins (LAMPs) including avian LEP100
(14), humanlamp-1 and lamp-2 (15, 61), mouse LAMP-1 and
LAMP-2 (8, 10), and rat 1gp110 and 1gpl20 (20,24) has been
described. The surface expression ofLAMPs is low (36, 37)
or undetectable (28) . However, deletion of the cytoplasmic
tyrosine from the short (11 amino acids) cytoplasmic tail of
human lamp-1 inhibits its transport to lysosomes such that
it accumulates at the cell surface (65). It has been proposed
that the route of LAMPs to lysosomes is via the same M6P
receptor-rich prelysosomal compartment described for pro-
teinscontaining the M6P lysosomal targeting signal (21). We
show here that an endogenous MDCK lysosomal membrane
glycoprotein, recognized by the AC17 monoclonal antibody,
exhibits identical properties to transfected LEP100 and tran-




MDCK II cells were grown in Dulbeccds minimum essential medium
(DMEM) (Gibco Laboratories, Grand Island, NY) supplemented with 5%
fetal bovine serum (Hyclone Laboratories Inc., Logan, UT), glutamine,
and nonessential amino acids (Gibco Laboratories) in an air-5% CO2 at-
mosphere at constant humidity. When grown on filters, 2 x 106 cells were
seeded on 24.5-mm Transwell polycarbonate filters (Costar Corp., Cam-
bridge, MA) and cultured for 5-7 d with changes of medium every other
day. Transepithelial resistance was measured using a Millipore device (Mil-
lipore Corp., Bedford, MA) and was typically 200-300 Q-cm2. Primary
cultures of quail fibroblasts were the kind gift of Dr. Takashi Mikawa
(Department of Cell Biology, Cornell University Medical College, New
York) and were cultured in DMEM supplemented with 10% fetal bovine
serum, glutamine, and nonessential amino acids. All chemicals were from
Sigma Chemical Co. (St. Louis, MO) unless otherwise indicated. The
Stella 2.1 modeling program was purchased from High Performance Sys-
tems (Hanover, NH).
Tlransfection ofLEPI00 cDNA into MDCK Cells
The major EcoRl fragment encompassing the LEP100 cDNA (14) was in-
serted into the EcoR.Icloning siteofthepYcos expression vector (41). Trans-
fection of MDCK cells was performed by a modification of the cal-
cium-phosphate precipitation procedure as described previously (18, 19).
LEP100-expressing clones were selected by immunofluorescence with the
CV24 anti-LEP100 mAb (36). Over 90% of the cells from the LEP-3176
clone expressed LEP100 and this clone was used for all subsequent studies.
Antibodies
The mouse AC17 mAb (IgGi) was produced by immunization of BALB/c
mice with MDCK cells detached with PBS/EDTA and injected in-
traperitoneally (106cells/mouse). Boosts with the same material were done
at days 20, 40, 51, 52, and 53 and the mouse was killed at day 54. Hybrid-
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omas between spleen cells and NS1 myeloma cells were produced as previ-
ously described (31). Hybridoma supernatants were screened by im-
munofluorescence ofwoundedMDCKmonolayers andpositive cloneswere
subcloned twice by limiting dilution. Ascites fluid was produced from the
intraperitoneal injection of 3 x 106 AC17 hybridoma cells into pristane
treatedBALB/c mice. Scatchard analysisofbinding toAC17 antigeninfixed
permeabilized cells shows a Kd of -5 nM for the AC17 mAb. For some ex-
periments monoclonal IgGs were purified from ascites fluids and
125I-
iodinated by the iodogen method (56). A polyclonal rabbit antiserum was
generated by immunizing rabbits with the peptide KSHAGYQTI, corre-
sponding to the COOH terminus ofthe cytosolic tail ofavian LEP100 and
mammalianLAMPI, covalently linked to keyhole limpet hemocyanin. Anti-
peptide antibody was isolated by amity chromatography on a peptide
column.
Metabolic Labeling
Confluent monolayers of LEP-3F6 MDCK cells grown on filters for 5-7 d
were incubated in methionine/cysteine-free DMEM containing 0.2% BSA
for 30 min and then pulse-labeled with 35S-Express (160 uCi/filter; New
England Nuclear, Boston, MA) for 20 min on the basolateral surface.
Steadi y-state metabolic labeling was performed by the incubation offilters
with 5S-Express (80 jaCi/filter) in methioninelcysteino-free DMEM sup-
plemented with 0.1 vol complete medium overnight. Cells were chased in
complete medium supplemented with cold methionme and cysteme as do-
scribed for individual experiments before lysis of the cells.
Immunoprecipitation and Immunoblots
The AC17 antigen and LEP100 were immunoprecipitated by incubation of
cell lysates with protein A-Sepharose beads (Pharmacia LKB Biotechnol-
ogy Inc., Piscataway, NJ) coated sequentially with rabbit anti-mouse anti-
bodies (Cappel Laboratories, Malvern, PA) andthe AC17 or CV24 mAbs,
respectively, as previously described (32). For endoglycosidase F (endo F)
and endoglycosidase H (endo H) (Boehringer Mannheim Corp., Indi-
anapolis, IN) treatments, the immunoprecipitates were eluted by boiling for
5 min in 0.1% SDS and 0.1 M sodiumcitrate containing a protease inhibitor
mix and digested with 0.1 U endo F for 6 h or 1 mU of endo H for 16 h
at 37°C. The immunoprecipitated samples were analyzed by SDS-PAGE
8% (29) andthe dried gels wereprocessed forfluorography (9). Where indi-
cated, MDCKcells were extracted with 1% Triton X-114 (3) and the deter-
gent and aqueous phases formed at 37°C wereanalyzedby SDS-PAGE and
protein blotting onto nitrocellulose as previously described (60) and AC17
mAb binding revealed with 1251-protein A (New England Nuclear). Auto-
radiographswere obtained from radiolabeled gels and blotsusing preflashed
film (Eastman Kodak Co., Rochester, NY). Quantitation ofthe intensity of
labeled bands was taken from the average of three passes through the left,
middle, and right areas ofan individual band using a scanning densitometer
(model GS300; Hoefer Scientific Instruments, San Francisco, CA). Com-
parisons were made between bands of intensities falling within the linear
response range of the densitometer.
Surface Immunoprecipitation
Cells on filters pulse-labeled with 35S-Express for 20 min in methio-
nine cysteine-free medium were chased at 37°C in the presence ofnormal
medium containing AC17 mAb (50x diluted ascites fluid, final mAb con-
centration -100 ug/ml) in the apical (0.5 ml) or basolateral (1 ml) medium
for the indicated period oftime. The filters were washed five times for 15
min with PBS/CM containing 0.5% BSA at 4°C. The cells were lysed at
4°C in lysis buffer (1% Triton X-100, 20 mM Tris, pH 8,150 mM NaCl,
5 mM EDTA, 0.2% BSA, and a mix of protease inhibitors) and precleared
for 1 h with BSA conjugated to CNBr-activated Sepharose 4B (Pharmacia
LKB Biotechnology Inc.). Antigen-antibody complexes were precipitated
at 4°C for 2 h with rabbit anti-mouse protein A-Sepharose beads and ana-
lyzed by SDS-PAGE and fluorography as described above.
Biotin Hydrazide Labeling ofSurface Glycoproteins
Exposedglycoproteins onthe surfaceofMDCKcells werelabeled as previ-
ously described with minor modifications (39). To enhance detection,
confluentmonolayers ofLEP3176 MDCK cellswereincubated twice for 30
min with 10 mM periodate and then twice for 30 min with 2 mM biotin-X-
hydrazide (CalbiochemCorp., LaJolla, CA) addedat 4°C to either the a
cal or basolateral surfaces before immunoprecipitation, blotting, and '91 1:
streptavidin labeling.
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Procedures for indirect immunofluorescence of MDCK cells were as de-
scribed (52) . For intracellular staining, cells fixed with 3% paraformalde-
hyde were permeabilized with 0.075% (wt/vol) sapomn. 0.5-wm frozen
sections ofMDCK cells on collagen (32) were processed for immunofluo-
rescence as described (59) . Fluorescent double labeling of cells was per-
formedwith the AC17 and CV24 niAbs using FIX-conjugated CV24mAb
or with the AC17 mousemAb and polyclonal rabbit and-tail peptide anti-
body. Endocytosis of the CV24 and AC17 mAbs was assayed as previously
described (65) . All fluorescent secondary antibodies were purchased from
Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA) . Fluores-
cently labeled cells on cover slides were mounted in gelvatol (Monsanto
Chemical Co., St . Louis, MO) and photographed with a Leitz Ortholux
epifiuorescence microscope using 400 ASA TMAX film (Kodak) .
Immunoperoxidase Labeling andElectron Microscopy
Immunoperoxidase localization of the AC17 antigen and LEPI00 to lyso-
somes was performed as previously described (36) . Immunolabeled sam-
ples werepostfixed in 1% osmiumtetroxide, dehydrated in agraded ethanol
series, and embedded in Epon . Thin sections were observed in an electron
microscope (JEOL U.S.A . Inc ., Peabody, MA) .
Results
Expression ofLAMPSinMDCK Cells
Monoclonal antibodies generated against MDCK proteins
were screened by immunofluorescent labeling of wounded
MDCK monolayers . One monoclonal antibody, designated
AC17 (IgG,), recognized distinct vesicular structures char-
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Figure 1. Localization of the
AC17 antigen in MDCK cells.
Semi-thin frozen sections . of
MDCK cells were immuno-
fluorescently labeled with the
AC17 mAb (A) . The corre-
sponding phase image is shown
inB. Bar = 5P .m .
acteristic oflysosomes (Fig. 1) . To characterize the expres-
sion of this protein, an exogenous lysosomal glycoprotein,
avian LEP100, was transfected into MDCK cells (14, 36,
37) . Gentomycin-resistant clones were selected for LEP100
expression by immunofluorescent labeling with the CV24
anti-LEP100 mAb . All expressing clones exhibited a typical
lysosomal fluorescent staining pattern and one such clone,
labeled LEP-3F6, was used for all subsequent studies .
LEP100 expressed in MDCK cells has a molecular mass of
110kD compared with the 100kD ofthe endogenous protein
expressed in quail fibroblasts (Fig. 2) . Endo F digestion to
remove N-linked oligosaccharides revealed that the polypep-
tide core of both exogenously expressedLEP100 in MDCK
cells and endogenous LEP100 in quail fibroblasts had an
identical size of 46 W, as previously reported (36) . The in-
creased apparent molecular weight of LEP100 in MDCK
cells is probably the result of differences in the structure of
the complex N-linked oligosaccharide chains . The AC17
mAb recognizes a glycoprotein of 95 kD in MDCK cells,
which when digested by endo F yields a product of 40 kD
(Fig . 2), different from LEP100 but characteristic of lyso-
somal membrane glycoproteins (28) . There is no crossreac-
tivity between the two antibodies : the AC17 antibody does
not reactwith chicken fibroblasts (data not shown) andCV24
does not crossreact with MDCK cells (Fig . 3) . After extrac-
tion with Triton X-114 theAC17 antigen partitions predomi-
nantly in the detergent phase, indicating that it is an integral
membrane glycoprotein (Fig . 2 C) .
Figure 2 . Expression ofLEP100 and the AC17
antigen in MDCK cells . (A) LEP100 was im-
munoprecipitated from [35S]methionine/cysteine
pulse-labeledMDCK LEP-3F6 cells (lanes a and
b) or quail fibroblasts (lanes c and d) and the
samples in lanesband dwere treated with endo
F . (B) LEP100 (lanes a and b) and the AC17 anti-
gen (lanes c and d) were immunoprecipitated
from pulse-labeled LEP100 transfected MDCK
cellsandthe samples in lanes b anddweretreated
with endo F (C) MDCK cells were extracted
with Triton X-114 and the aqueous (a) and deter-
gent (b) phases were blotted with the AC17 n Ab .The vesicular structures immunofluorescently labeled by
theAC17mAb were determined to be lysosomes by the com-
plete colocalization of the AC17 antigen with transfected
LEP100 as well as with the endogenous antigen recognized
by a rabbit polyclonal antibody raised against a synthetic
peptide corresponding to the conserved carboxy-terminal
amino sequence of the cytoplasmic tail of mammalian
LAMP-1 (Fig. 3) . Immunoperoxidase electron microscopy
with the CV24 and AC17 mAbs revealed characteristic
lysosomal structures (Fig. 4) .
ProcessingandLifetime ofLysosomal Glycoproteins in
MDCK Cells
To determine the rate ofpassage of newly synthesized AC17
antigen and LEP100 through the Golgi, pulse-chase experi-
ments were carried out on LEP3F6 cells (Fig. 5 A) . The im-
munoprecipitated proteins were treated overnight with endo
H to remove unprocessed high-mannose oligosaccharide
chains . As previously described, both proteins acquire endo
H resistance with a t i/2 of 25 min, reflecting the kinetics of
their transport to the Golgi apparatus (36) .
The extensive glycosylation of lysosomal glycoproteins
endows them with resistance to lysosomal degradation and
an extremely long lifetime within the cell (28) . Pulse-chase
labeling of LEP3F6MDCK cells with [ 31S]methionine and
cysteine followed by chases of varying lengths of time in
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Figure3 Colocalization ofthe
AC17 antigen with lysosomal
membrane glycoproteins. LEP-
100 transfected MDCK cells
were fixed, permeabilized,
and immunofluorescendy la-
beled with the AC17 mAb fol-
lowedby'Ibxas Red-conjugated
anti-mouse secondary anti-
body (A) and then with F1TC-
conjugatedCV24 anti-LEP100
mAb (B) . Alternatively, un-
transfected MDCK cells were
labeled with the AC17 mAb
followed by Texas Red anti-
mouse secondary antibody (C)
and then with a rabbit poly-
clonal anti-peptide antibody
against the cytoplasmic tail of
LEP100 Mowed by FITC-
conjugated anti-rabbit secon-
dary antibody (D) . Identical
fields were photographed inA
andBand inCandDusing fil-
ters for rhodamine (A, C) or
fluorescein (B, D) fluores-
cence . No crossover offluores-
cence was detected between
the rhodamine and fluorescein
channels . The lack of fluores-
cein fluorescence in the non-
expressing cell in the upper
right-hand comers ofA and B
demonstrates the specificity of
the double labeling with the
two mouse monoclonal anti-
bodies. Bar = 5 Am .
isotope-free medium revealed that in MDCK cells both
transfected LEP100 and endogenous AC17 antigen are ex-
tremely stable proteins . Both proteins are synthesized as
precursors of lower molecular weight and acquire their ma-
ture size within 1 h of chase (Fig . 5 B) . Approximately 70%
of the pulse-labeled LEP100 andAC17 antigen are still pres-
ent after 23 h of chase, which, when extrapolated, indicates
a tz of 120-150 h for both proteins.
Surface Expression of theAC17Antigen andLEP100
inMDCK Cells
The extensive glycosylation of lysosomal glycoproteins al-
lowed us to detect both LEP100 andAC17 antigen by perio-
date oxidation of cell surface carbohydrates and reaction
with biotin-X-hydrazide followed by immunoprecipitation
and "11-streptavidin blotting (Fig . 6) . Equivalent amounts
of the two proteins were detected on the apical and baso-
lateral surfaces . In chick embryo fibroblasts 2-3% of total
cellular LEP100 is found on the cell surface by radioimmu-
noassay (37) . Using a similar approach with iodinated AC17
and CV24 mAbs we determined the apical, basolateral, and
intracellular distribution of AC17 antigen and LEP100 in
LEP3F6 MDCK cells (Table I) . Both proteins were local-
ized predominantly intracellularly (97 %) with 0.8% of the
total cellular protein found on the apical surface and 2.1%
on the basolateral surface . Pretreatment of the cells for 5 hFigure 4 . Inununoperoxidase labeling demonstrates the lysosomal
localizationofLEP100 andAC17 antigen inMDCK LEP-3F6 cells .
Cells were fixed with formaldehyde in buffer containing 0.02%
saponin and incubated with either theCV24 (A) or AC17 (B) mAb
followed by HRP-conjugated anti-mouse F,b fragmentsand visual-
ized by electron microscopy. Bar = 0.2 um .
with 0.1 mM chloroquine resulted in an approximately two-
fold increase in the apical expression buthadno effect on the
basolateral expression of either protein (Fig . 6) .
SurfaceImmunoprecipitation ofLysosomal
Membrane Glycoproteins
Anti-LEP100 antibodies addedto viable chicken fibroblasts
are specifically taken up by surface-expressed LEP100 and
transported to lysosomes (36, 37) . Similarly, anti-lamp-1 an-
tibodies addedto h-lamp-1 transfectedCOScells at 37°C are
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Figure S . Biosynthetic processing and degradation of lysosomal
glycoproteins in MDCK cells. MDCK cells were pulse-labeled
with [35S]methionine/cysteine for 20 min and chased for the indi-
cated times before lysis and immunoprecipitation with the CV24
(left-most lanes) or AC17 (right-most lanes) mAb. (A) After 0, 10,
20, 30, 40, or 50 minofchase the precipitated proteins were treated
with endoH. Unprocessed LEP100 (adoublet of46/40kD)andthe
AC17 antigen (40 kD) are indicated with arrowheads, while the
processed forms are indicated with arrows . High mannoseN-linked
oligosaccharides on both proteins were processed with a tZ of
N25 min (B) . Cellswere chased for 0, 1, 2, 4, 8, or 23 hbefore
lysis. The precursorform ofLEP100 (95 kD) and theAC17 antigen
(85 kD) are indicated by arrowheads, while the mature forms are
indicated by arrows to the left and right of the figure, respectively.
Densitometric analysis and extrapolation reveals a tj/2 for the two
proteins of 120-150 h.
Figure 6 . Steady-state surface expression of lysosomal glycopro-
teins inMDCK cells . Confluent monolayers of LEP100 transfected
cells on filters were treated at4°Cwith 10 mM periodate followed
by biotin-X-hydrazide to label cell surface glycoproteins. LEP100
(CV24) and the AC17 antigen were immunoprecipitated from
monolayers labeled from the apical (Ap) or basolateral (B!) sur-
faces.Where indicated, the cellswere treated with 0.1 mM chloro-
quine for 5 hbefore cell surface labeling. Control labeling in the
absence of periodate treatment (-) revealed no labeling of either
LEP100 or the AC17 antigen, indicating the specificity ofthe label-
ing for oligosaccharide residues, while other nonspecifically la-
beledbands were still present . The increasedmolecular weight of
thetwo proteins probably reflects the presence of multiple biotins
per molecule .















LEP-3F6MDCK cells grown on 6-mm Transwell filters were incubated with
1"I-labeled AC17 or CV24 antibody on the apical or basolateral surfaces at
4°C . The values represent surface binding as a percent of antibody binding to
saponin permeabilized cells . All values were corrected for nonspecific binding
in the presence of cold antibody .
transported to lysosomes (65) . We have used a similar ap-
proach to study the surface expression of lysosomal glyco-
proteins in MDCK cells. As seen in Fig . 7, incubation of
viableMDCK LEP3F6 cells at37°C with monoclonal anti-
bodies against either LEP100 orAC17 antigen for 30min fol-
lowed by a60-min chase sulted inthe accumulation of anti-
body in vesicular lysos mal structures . In untransfected
MDCK cells, only antibodies against the endogenously ex-
pressed AC17 antigen are detectable in lysosomes . No stain-
ing was visible after addition of theCV24 anti-LEP100 anti-
body to untransfected MDCK cells (Fig . 7 D) or after
addition of equivalent concentrations ofnonimmune mouse
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IgG (not shown) to either transfected or untransfected
MDCK cells, suggesting that antibody uptake under these
experimental conditions is due to specific antibody-antigen
interaction and not to nonspecific fluid phase uptake.
We used the ability to "catch" lysosomal glycoproteins by
the addition of antibodies to the culturemedium to study the
domain-specific passage of newly synthesized MDCK lyso-
somal glycoproteins . To ensure that lysosomal glycoprotein
surface expression was not due to the redirection ofan over-
expressed transfected protein to the cell surface, we studied
the trafficking of the endogenous MDCK lysosomal mem-
brane glycoprotein recognized by theAC17 mAb . Cells were
pulse labeled with [35S]methionine and cysteine for 20 min,
chased in the absence of antibody for 10 min, and then
incubated with the AC17 mAb in the apical or basolateral
chase media for 45, 90, or 180 min . As seen in Fig . 8, AC17
antigen is detected basolaterally within 45 min . Extended
incubation with antibody for 180 min on the basolateral
surface results in a decreased detection of the antigen, per-
haps reflecting arrival of the antigen-antibody complex to
lysosomes were the acidic intraluminalpH may disrupt anti-
gen-antibody interaction . No AC17 antigen was detected
apically at any time point, indicating that newly synthesized
AC17 antigen is targeted to the basolateral domain, encom-
Figure 7 . Uptake of the AC17 and CV24 mAbs by MDCK cells . Sparsely plated LEP100 transfected (A and B) or untransfected (C and
D) MDCK cells on cover slides were incubated with the AC17 (A and C) orCV24 (B and D) mAb for 30 min in medium and then chased
in antibody-free medium for 1 h at 37°C. The cells were then fixed, permeabilized, and incubated with rhodamine-conjugated anti-mouse
secondary antibodies. No uptake of an equivalent concentration of nonimmune IgG was observed (identical image to D) . Bar = 5 jm .Figure 8 . Surface appearance of 35S-labeled AC17 antigen . Con-
fluentmonolayers ofMDCK cells on filters were pulse-labeled with
[35S]met/cys for 20 min, chased for 10 min, and then chased for
45, 90, or 180 min in the presence of the AC17 mAb added to the
apical or basolateral surface as indicated . Antigen-mAb complexes
were recovered from detergent extracts of the cells by immune
precipitation and the labeled AC17 antigen was detected by SDS-
PAGE and fluorography. AC17 antigen could not be detected api-
cally in the absence ofchloroquine (-Chlor) but appeared apically,
although retarded relative to its basolateral appearance, after treat-
ment of the cells for 5 h with 0.1 mM chloroquine (+Chlor) .
passing both the basolateral cell surface and basolateral
early endosomes, before transport to lysosomes . The lack
of 35S-labeled AC17 antigen detected apically precludes the
possibility that 35S-labeled AC17 antigen was precipitated
due to fluid phase uptake and transport of the antibody to
prelysosomes or lysosomes or resulted from antibody ex-
change with labeled molecules during subsequent experi-
mental manipulations .
Effect ofChloroquine on Targeting
oftheACl7Antigen
After treatment ofcells for 5 h with 0.1 mM chloroquine, ex-
pression of the AC17 antigen does not decrease with time in
the basolateral domain and can be detected in significant
amounts in the apical domain consistent with the enhanced
surface expression ofLEP100 in chloroquine-treated fibro-
blasts (Fig . 8) (37) . The de novo appearance of AC17 an-
tigen in the apical domain following chloroquine treatment
corresponds to the increase in steady-state AC17 antigen lev-
els detected on the apical surface by biotin hydrazidelabeling
(Fig . 6) . Apical appearance is delayed relative to basolateral
appearance and detection of theAC17 antigen after antibody
incubation for 180 min is not decreased, consistent with the
depletion ofLAMPs from lysosomes in the presence ofchlo-
roquine (37) .
Targeting of theAU7Antigen
To follow the time course of basolateral expression of newly
synthesized AC17 antigen, surface-capture by AC17 antigen
was monitored both apically and basolaterally for discrete
time periods after pulse labeling with [s5S]methionine/cys-
teine. The newly synthesized AC17 antigen appeared tran-
siently basolaterally with a t112 of appearance of 35 min,
comparable to the surface delivery of basolateral surface
proteins inMDCK cells (33) . Expression peaked 60 min af-
ter the pulse and then diminished with a tz of 35 min, indi-
cating the removal ofthe AC17 antigen from the surface and
early endosomes and its redirection to lysosomes . Consider-
ing the time required for exit from the Golgi (t12 = 25 min
based on acquisition of endo H resistance), the rapid transit
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of the AC17 antigen to the basolateral domain is not consis-
tent with its prior delivery to lysosomes (Fig . 11) . No apical
35S-labeled antigen was detected at any time point, suggest-
ing that the AC17 antigen is routed from the Golgi apparatus
exclusively to the basolateral surface or basolateral earlyen-
dosomes. As seen in Fig . 8, in the presence of chloroquine
newly synthesized AC17 antigen is targeted basolaterally and
is then more stably expressed in both the apical and
basolateral domains (Fig. 9 B), consistent with the nonpolar
distribution of lysosomes in MDCK cells (Fig . 1) .
74%ofNewly SynthesizedAC17Antigen Pusses
through theBasolateralDomain
The efficient surface capture achieved in the short 15-minan-
tibody incubations of the targeting experiments (Fig. 9)
strongly suggests that precipitated AC17 antigen interacts
with the antibody on the surface, or perhaps within baso-
lateral early endosomes, but not within late endosomes (pre-
lysosomes), since these are reached by fluid phase endocy-
tosis in MDCK cells only after 15 min from both the apical
and basolateral surfaces (2, 47) . Furthermore, addition of
antibody for even shorter periods, such as 5 or 10 min,
results in the precipitation ofAC17 antigen in amounts pro-
portional to the time of incubation (Fig . 10 A), precluding
interaction of theAC17 antibody with its antigen in prelyso-
somes .
To determine whether the basolateral expression of the
AC17 antigen is due to mistargeting oflysosome-bound pro-
Figure 9 . Surface targeting of the AC17 antigen. MDCK cells were
pulse-labeled for 20 min with [35S]methionine/cysteine and chased
in the presence of the AC17 mAb as follows. (A) At 0, 20, 40, 60,
80, and 100 min after the pulse, the AC17 mAb was added in
medium to the apicalor basolateral surface for 15 min and captured
AC17 antigen was analyzed as in Fig . 8. The AC17 antigen was not
detected apically and arrived to and disappeared from the
basolateral domain with a t2 of -35 min. In B, the cells were
treated with0.1 mM chloroquine for5h before surface immunopre-
cipitation and the AC17 mAb was added at two additional time
points of 120 and 140 min after the pulse. Apical AC17 antigen
could be detected after chloroquine treatment, but its delivery was
retarded relative to basolateral delivery.
1579Figure 10 . Quantitation ofsur-
face appearance of the AC17
antigen . (A) After 50 min of
chase following a 20-min pulse
of ["S]methionine/cysteine,
the AC17 mAb was added to
the basolateral medium for 5,
10, 15, or 20 min . The amount
of AC17 antigen captured in
these short time periods is
compared with that captured
by addition of antibody to the
basolateral surface from 10 to
90 min after the pulse (Surf)
and to the total AC17 'SS-la-
beled antigen precipitated from
detergent extracts with AC17 immunobeads (RI) . (B) After a 20-
min pulse or overnight labeling, the AC17mAb was added to either
the apical (Ap) or basolateral (BI) surfaces from 10 to 90 min after
the end of the labeling period . An identical filter chased in the ab-
sence of antibody was lysed and the AC17 antigen immunopre-
cipitated by addition of AC17 invnunobeads to the lysate (RI) .
After a pulse labeling, 74 f 12% (n = 5) ofthe total immunopre-
cipitable AC17 antigen could be recovered by surface immunopre-
cipitation .
tein to the cell surface or whether basolateral passage is the
constitutive route for the AC17 antigen to the lysosome, the
amount of AC17 antigen that could be detected by the addi-
tion of antibody to the basolateral medium was quantified .
After a 20-min pulse, cells were chased in the presence of
AC17 antibody on the apical or basolateral surface from 10
to 90 min, the time of basolateral delivery determined from
Fig . 9 . A parallel culture was chased in the absence ofmAb,
lysed, and then immunoprecipitated to determine the total
amount of labeled AC17 antigen in the sample (Fig . 10 B) .
While no AC17 antigen was detected apically, as expected,
74 f 12% (n = 5) of the total immunoprecipitable protein
was recovered by basolateral surface immunoprecipitation .
In contrast, after overnight labeling to generate a steady-
state pool of labeled molecules, a small proportion of total
labeled AC17 antigen was detected both apically and basolat-
erally (Fig . 10 B) . While the basolateral signal is clearly
greater than the apical signal, the extended exposure required
to visualize the surface immunoprecipitated protein, result-
ing in overexposure ofthe total protein band and appearance
of a background band just above the AC17 antigen, made
quantification of the apically and basolaterally expressed
AC17 antigen difficult. The detection ofsmall amounts ofthe
AC17 antigen both apically and basolaterally by surface im-
munoprecipitation after overnight labeling corroborates our
finding by 'III-labeled mAb binding and by biotin hydrazide
surface labeling that the AC17 antigen is found on both sur-
faces at steady state . The greater basolateral accumulation
of AC17 antigen and LEP100 may be due in part to the
continual targeting of newly synthesized molecules to that
domain . The discrepancy in degree and polarity ofthe distri-
bution of surface immunoprecipitated'SS-labeled AC17 an-
tigen after pulse and overnight metabolic labeling is best ex-
plained by the polar delivery of the AC17 antigen via the
basolateral surface and early endosomes to prelysosomes
and lysosomes from which it shuttles in small amounts, as
reported forLEP100 in chick fibroblasts (37), to both the ap-
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ical and basolateral surface domains in a nonpolar fashion
(Fig . 11) .
Discussion
To characterize the pathway to lysosomes in epithelial cells,
we have studied the expression of an endogenous lysosomal
membrane glycoprotein inMDCK cells . A monoclonal anti-
body, AC17, recognizes distinct vesicular structures by im-
munofluorescent labeling. These structures were identified
Figure 11. Schematic repre-
sentation of the trafficking of
the AC17 antigen . (A) After
biosynthesis, newly synthesized
AC17 antigen is targeted from
theGolgi apparatus (G) to the
basolateral plasma membrane
and/or early endosomes and
from there transferred to lyso-
somes (L) via basolateral early
endosomes (EE(BL)) and pre-
lysosomes (PL ; heavyarrows) .
The AC17 antigen recycles at
low levels from lysosomes
to prelysosomes and the api-
cal and basolateral domains
(dashed arrows) . In the pres-
ence ofchloroquine,the move-
ment of the AC 17 antigen
from the prelysosome to lyso-
some is blocked (6) and recy-
cling with both the apical and
basolateral domains accentu
ated (a) . The diagram represents the fusion of vesicles budding
offtheTUN withbasolateral early endosomes and cell surface recy-
cling from the prelysosome . However, our results cannot distin-
guish between targeting from the TGN directly to the basolateral
surface orthrough an early endosomal compartment nor determine
from which intracellular compartment recycling occurs. (B) Using
the Stella modeling program on a Macintosh computer, a model
was generated incorporating the various steps of AC17 trafficking
outlined inA. Using the known parameters ofacquisitionofendo H
resistance in the Golgi apparatus (circles) and basolateral appear-
ance (squares) and assuming similar kinetic parameters for AC17
endocytosis and recycling as described for LEP100 in chick fibro-
blasts (37), the Stella program generated a model consistent with
the rapid passage of the AC17 antigen to lysosomes (LYS). The
model incorporated the experimental data of passage through the
Golgi (Fig. 5 A), basolateral expression (Fig . 9), and lysosomal
degradation (Fig. 5 B) of the AC17 antigen . Rate constants for the
distribution and shuttling of LEP100 in chick fibroblasts (37) were
used to describe the endocytosis (k 1 = 0.33 min-'), exocytosis (k- 1
= 0.16 min -1 ), and shuttling from endosome to lysosome (k2 =
0.067 min- ) . A fivefold decreased rate of recycling from lysosome
to endosome (k-2 = 0.00083 min') of the AC17 antigen, relative
to LEP100, was used due to the minimal effect of chloroquine on
steady-state AC17 antigen surface expression inMDCK cells (Fig .
6) compared with that found for LEP100 in chick fibroblasts (37) .
Not unexpectedly, this change was not found to significantly affect
the rate of arrival of the AC17 antigen to lysosomes. 1b simplify
the model a single endosomal compartment was used correspond-
ing to theearly endosome. Altering of themodelto incorporate tar-
geting of vesicles from the Golgi to either the plasma membrane
or the early endosome did not significantly affect the rate ofarrival
of the AC17 antigen to the lysosome .
1580as lysosomes by their identical colocalization with the major
protein component of the lysosomal membrane, the highly
glycosylated membrane proteins referred to as lysosomal as-
sociated membrane proteins (LAMP) or lysosomal glyco-
proteins (lgp) (28). In MDCK cells, the AC17 antigen
colocalizes with transfected LEP100, the avian LAMP (14,
36, 37), and an endogenous MDCK antigen recognized by
a polyclonal antibody raised against the highly conserved cy-
toplasmic tail of LEP100 (Fig. 3) ; the labeled structures ex-
hibited a typical lysosomal morphology by immunoelectron
microscopy (Fig. 4). LAMPs typically have a molecular size
between 100 and 120 kD with a core protein of -40 kD.
They are synthesized as precursor molecules of 90 kD con-
taining 17-20 N-linked high mannose oligosaccharides that
are processed to complex oligosaccharides containing a
large amount of polylactosamines (28). The endogenous
MDCK lysosomal glycoprotein recognized by the AC17
monoclonal antibody partitions to the detergent phase fol-
lowing Triton X-114 extraction, is synthesized as a precursor
molecule of 85 kD, has a molecular size of 95 kD, and has
a core polypeptide of40 kD. The time course of acquisition
ofendo H resistance and of protein degradation for the AC17
antigen is identical to that of LEP100 expressed in the same
transfected MDCK clonal cell line. These characteristics
strongly indicate that the AC17 antigen is an endogenous
MDCK LAMP
In chick fibroblasts, LEP100 has been shown to be local-
ized primarily to lysosomes (90%) but is also present in the
plasma membrane (3 %) and in endosomes (7%) (36, 37).
Other LAMPs are barely detectable at the cell surface (28).
By three different methods, we demonstrated low levels of
surface expression of both transfected LEP100 and the en-
dogenous AC17 antigen on the apical (0.8%) and basolateral
(2 .1%) membranes of MDCK cells. LEP100 mAb added to
chick fibroblasts at 37°C is specifically endocytosed to lyso-
somes, as are LAMP antibodies added to h-lamp-1 trans-
fected cells (37, 65). Similarly, both AC17 and CV24 mAbs
were taken up by LEP-3F6 MDCK cells and delivered to
lysosomes (Fig. 7). The inability of untransfected MDCK
cellsto take up anti-LEP100 demonstrates the specificity of
this delivery from the cell surface to lysosomes.
Interestingly, in contrast to its nonpolar steady-state sur-
face distribution, newly synthesized AC17 antigen was tar-
geted in a highly polar fashion. After a [35S]methionine/
cysteine metabolic pulse, the AC17 antigen was surface im-
munoprecipitated by the continuousaddition ofmAb at 37°C
to the apical or basolateral medium; antibody-antigen com-
plexes formed were collected by precipitation after cell lysis.
Newly synthesized AC17 antigen couldonly be detected after
addition of antibody basolaterally ; extended incubation (180
min) resulted in a decreased signal, probably due to the ar-
rival of antigen-antibody complexes to the lysosome. Addi-
tion of antibody for discrete (15 min) time periods indicate
a tan of delivery to and removal from the basolateral do-
main ofti 35 min, in agreement with kinetic studies ofsurface
expression ofLEP100 inchickfibroblasts, which revealed an
extremely short residence time at the plasma membrane (tan
= 2 min) . In contrast, continuous presence of antibody in
the apical medium during the chase detected no AC17 anti-
gen. Apical and basolateral fluid phase markers have been
shown to mix 15 min after addition of fluid phase marker in
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a late endosomal (prelysosomal) compartment (2, 47). The
absenceof apical detection andour ability to detect AC17 an-
tigen after addition of basolateral antibody for only 5 min
(Fig. 10) indicates that we are detecting AC17 antigen at the
basolateral cell surface or within basolateral early endo-
somes and not within prelysosomes reached by fluid phase
uptake of antibody.
These results contrast with a previous report (21), which
suggested that two integral membrane lysosomal glycopro-
teins, 1gpll0 and lgp120, are not targeted to lysosomes in
fibroblasts via the cell surface but rather through an acidic
prelysosomal compartment, the route followed by M6P con-
taining lysosomal hydrolases (62). This conclusion was
based on the inability to detect lgp's at the cell surface and
on the rapid delivery of these proteins to lysosomes (t1rz =
45 min), which, when compared with the rates of plasma
membrane protein delivery to the cell surface and of mem-
brane bound endocytic markers to lysosomes, was judged to
preclude a passage of lysosomal glycoproteins through the
cell surface. The low levels of surface expression of LAMPs
could be ascribed to reequilibration ofthe proteins between
lysosomes and the cell surface or to missorting in the Golgi
due to oversaturation of sorting receptors, and would not
reflect the major pathway of LAMPS out of the Golgi (28).
Our ability to detect the transient surface expression of a
LAMP during biogenesis may be attributed to the approach
utilized (antibody "catch") and to the possession of a high
affinity monoclonal antibody against an endogenous MDCK
LAMP (Kd = 5 nM). Addition of the AC17 mAb to the
basolateral medium from 10 to 90 min after pulse labeling,
encompassing the peak of AC17 antigen basolateral appear-
ance, resulted in the recovery of 74 f 12% (n = 5) of the
total precipitable AC17 antigen. Considering the loss inher-
ent to any immunoprecipitation procedure and the possible
disruption of some antigen-antibody complexes upon arrival
to lysosomes, the detection of 74 % of the total protein pulse
by surface immunoprecipitation indicates that newly synthe-
sized AC17 antigen is targeted basolaterally before delivery
to lysosomes.
The time course of AC17 antigen basolateral delivery is
similar to that described for the vectorial targeting of
basolateral proteins in MDCK cells (33) and is consistent
with the rapid delivery of LAMPs to lysosomes described
previously (21). The AC17 antigen acquires endo H resis-
tance with a tan of 25 min and is detected basolaterally with
a t1n of 35 min such that transport from the Golgi apparatus
tothe basolateral domain requires -10 min. Considering the
short residence time of LEP100 on the cell surface and its
rapid transport to lysosomes (37), these values support the
delivery ofthe AC17 antigento lysosomes via the cell surface
and early endosomes with a tan of 45-60 min. Computer
modeling of the pathway of the AC17 antigen to lysosomes
incorporating the known parameters of acquisition of endo
H resistance in the Golgiapparatus and passage of the AC17
antigen through the basolateral domain confirm that the
basolateral targeting of the AC17 antigen is consistent with
its rapid delivery to lysosomes (Fig. 11). Similar rates of ar-
rival of the AC17 antigen to lysosomes were predicted from
models incorporating either direct vesicular fusion with the
basolateral surface or fusionwith early endosomes and rapid
recycling between the early endosome and the basolateral
158 1surface. It is therefore possible that some AC17 antigen may
be transported to the lysosome by way of basolateral early
endosomes without appearing on the cell surface.
The detection of AC17 antigen surface expression by addi-
tion of antibody at 37°C does not rule out the possibility
of fluid phase endocytosis of antibody and its interaction
with antigen in basolateral early endosomes. Endocytosed
alpha2-macroglobulin, which is targeted to lysosomes after
release from its receptor within the early endosome, reaches
a compartment inaccessible to fluid phase uptake (fusion-
inaccessible) with a t,a of 8 min (57). AC17 antigen endo-
cytosis may be better represented by studies oflysosome tar-
geted transmembrane VSV G protein implanted into the
plasma membrane and then crosslinked by antibody which
reaches a fusion-inaccessible compartment with a tv2 of <5
min (23) . AC17 antigen that transited only the early endo-
some en route to lysosomes would therefore reside in a com-
partment accessible to fluid phase uptake of antibody for a
very short period of time and we question whether our re-
sults can be explained by AC17 antibody-antigen interaction
within intracellular compartments. The significantly greater
rate of endosome to surface recycling (0.138 mint) relative
to the rate of endosome to lysosome transport (0.076 mint)
measured for LEP100 in chick fibroblasts (37) suggests that
any LAMP molecules that reach the early endosome must
necessarily also be expressed on the cell surface, ifonly very
transiently. Whatever the route taken, it is clear that the AC17
antigen transits a compartmentrapidly accessible to antibod-
ies within the basolateral but not the apical medium, either
the plasma membrane or the early endosome, and therefore
does not follow the direct TGN-prelysosome route to lyso-
somes which has been described for lysosomal hydrolases
(13, 62).
In the presence ofchloroquine, the expression ofthe AC17
antigen in MDCKcellswas dramatically altered. Newly syn-
thesized protein was still targeted first basolaterally, al-
though with slower kinetics, and could then be detected for
extended times in both the apical and basolateral domains.
Chloroquine has been shown to selectively block the path-
way of LEP100 to lysosomes, resulting in its depletion from
lysosomes and increased presence in endosomes and the
plasma membrane (37). The increased surface residence
time and the apical appearance of the AC17 antigen probably
reflect its arrival to an intracellular compartment from which
the protein can recycle to both the apical and basolateral do-
mains. This compartment is probably the prelysosome (late
endosome) where fluidphase markers endocytosed from the
apical and basolateral surfaces have been shown to meet
(47). This suggests that chloroquine specifically blocks the
path of the AC17 antigen from the prelysosome to the lyso-
some and that recycling with early endosomes and the
plasma membrane occurs from the prelysosome. Newly syn-
thesized AC17 antigen is therefore targeted to the basolateral
surface and/or early endosomes, endocytosed, and then
transferred via the endocytic pathway to lysosomes from
which it reequilibrates with prelysosomes and both apical
and basolateral early endosomes and plasma membranes
(Fig. 11).
The basolateral appearance of the AC17 antigen en route
to lysosomes is consistent with the finding that the pathway
of LAP, a transmembrane lysosomal enzyme lacking M6P,
to lysosomes is via the cell surface (4). LAP is rapidly trans-
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ported from the Golgi apparatus to the cell surface (in 10
min) and recycles between the cell surface and endosomes
more than 15 times before transport to lysosomes with a t,rz
of 6-7 h (4). Deletion of the cytoplasmic domain of LAP or
replacement of the tyrosine within the cytoplasmic domain
with another amino acid results in accumulation of the pro-
tein at the cell surface (48). Similarly, a tyrosine residue
in the cytoplasmic domain is critical for the targeting of
h-lamp-1 to lysosomes (65). The cytoplasmic tyrosine-con-
taining motif, while clearly an endocytic signal, is not in it-
selfsufficient to target proteins to lysosomes since it is pres-
ent in a number of receptors that recycle from endosomes to
the plasma membrane (12, 27). Additional unknown features
may be required to target proteins to lysosomes. Ongoing
studies ofAC17 antigen expression in MDCK cells will help
define the mechanismsinvolved in this novel biogenetic path-
way in polarized epithelia.
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Note Added in Proof. Sequencing by Edman degradation of 20 NH,-
terminal aminoacids ofAC17 antigen immunopurified fromdogkidney has re-
vealed significant sequence identity to human and mouse .LAMP-2. 15 of 18
identifiableaminoacidsare identical tohuman LAMP-2 andtwo ofthe noniden-
tical amino acids are present in the mouse LAMP-2 sequence. The high degree
of sequence identity indicates that the AC17 antigen is the dog homologue of
the LAMP-2 family of lysosomal membrane glycoproteins.
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